carvedigamma 12,5 mg filmsko obložene tablete
wÖrwag pharma - karvedilol - filmsko obložena tableta - karvedilol 12,5 mg / 1 tableta - karvedilol
carvedigamma 25 mg filmsko obložene tablete
wÖrwag pharma - karvedilol - filmsko obložena tableta - karvedilol 25 mg / 1 tableta - karvedilol
glucotrol xl 10 mg tablete s podaljšanim sproščanjem
pfizer luxembourg sarl - glipizid - tableta s podaljšanim sproščanjem - glipizid 10 mg / 1 tableta - glipizid
glucotrol xl 5 mg tablete s podaljšanim sproščanjem
pfizer luxembourg sarl - glipizid - tableta s podaljšanim sproščanjem - glipizid 5 mg / 1 tableta - glipizid
xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).
komboglyze
astrazeneca ab - metformin hidroklorid, saxagliptin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - komboglyze je navedena kot dodatek k prehrane in vadbe za izboljšanje glycaemic nadzor pri odraslih bolnikih, starih 18 let in starejši s sladkorno boleznijo tipa 2 neustrezno nadzorovano na njihovo maksimalno odmerkom metformin sam ali tiste, ki že zdraviti s kombinacijo saxagliptin in metformin kot ločene tablet. komboglyze je prikazano tudi v kombinaciji z insulin (i. trojna kombinacija terapija), kot dodatek k prehrani in vadbi za izboljšanje glycaemic nadzor pri odraslih bolnikih, starih 18 let in starejših s tipa 2 sladkorna bolezen, ko inzulin in metforminom sam ne zagotavljajo ustrezne glycaemic nadzor.
pioglitazone actavis
actavis group ptc ehf - pioglitazon hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapyin adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance. as dual oral therapy in combination withmetformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin. a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination withmetformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy. pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance (see section 4. po začetku terapije z pioglitazone, bolnike je treba pregledati in po 3 do 6 mesecev, da oceni ustreznost odziva na zdravljenje (e. zmanjšanje hba1c). pri bolnikih, ki ne kažejo ustrezen odgovor, pioglitazone, je treba prekiniti,. v luči možnih tveganj z dolgotrajna terapija, predpisovalce morajo potrditi na kasnejše redne preglede, da je korist pioglitazone je ohranjena (glej poglavje 4.
lenem 250 mg/250 mg prašek za raztopino za infundiranje
lek d.d. - cilastatin; imipenem, brezvodni - prašek za raztopino za infundiranje - cilastatin 250 mg / 1 viala imipenem, brezvodni250 mg / 1 viala; imipenem, brezvodni 250 mg / 1 viala - imipenem in cilastatin
lenem 500 mg/500 mg prašek za raztopino za infundiranje
lek d.d. - cilastatin; imipenem, brezvodni - prašek za raztopino za infundiranje - cilastatin 500 mg / 1 viala imipenem, brezvodni500 mg / 1 viala; imipenem, brezvodni 500 mg / 1 viala - imipenem in cilastatin
rosmela 10 mg/5 mg filmsko obložene tablete
krka, d.d., novo mesto - amlodipin; rosuvastatin - filmsko obložena tableta - amlodipin 5 mg / 1 tableta rosuvastatin10 mg / 1 tableta; rosuvastatin 10 mg / 1 tableta - rosuvastatin in amlodipin